FDA recall D-0255-2025

Zydus Pharmaceuticals (USA) Inc · Class II · drug

Product

Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1726-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1726-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ

Reason for recall

Failed Impurities/Degradation Specifications

Distribution

USA Nationwide

Key facts

Status
Ongoing
Initiation date
2025-02-13
Report date
2025-03-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Pennington, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0255-2025